Operating Income for AbbVie (ABBV)
According to AbbVie's latest reported financial statements, the company's current operating income (TTM) is $17.34B USD. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
ABBV
Currently viewingOperating IncomeSwitch metric
TTM (last 4 quarters)
$17.34B
YoY change
+119.9%
5Y CAGR
+12.1%
Peak year (2025)
$20.09B
Cumulative operating income
$163.34B
Operating Income history chart for AbbVie (ABBV) from 2009 to 2025
Operating Income history table for AbbVie (ABBV) from 2009 to 2025
| Fiscal year | Period ended | Reported | Operating Income | YoY | YoY change |
|---|---|---|---|---|---|
| 2025 | $20.09B | +119.9% | +$10.95B | ||
| 2024 | $9.14B | -28.4% | -$3.62B | ||
| 2023 | $12.76B | -29.6% | -$5.36B | ||
| 2022 | $18.12B | +1.1% | +$193.00M | ||
| 2021 | $17.92B | +57.7% | +$6.56B | ||
| 2020 | $11.36B | -12.5% | -$1.62B | ||
| 2019 | $12.98B | +103.4% | +$6.60B | ||
| 2018 | $6.38B | -33.1% | -$3.16B | ||
| 2017 | $9.54B | +2.2% | +$205.00M | ||
| 2016 | $9.34B | +23.9% | +$1.80B | ||
| 2015 | $7.54B | +121.0% | +$4.13B | ||
| 2014 | $3.41B | -39.8% | -$2.25B | ||
| 2013 | $5.66B | -2.6% | -$153.00M | ||
| 2012 | $5.82B | +60.7% | +$2.20B | ||
| 2011 | $3.62B | -23.3% | -$1.10B | ||
| 2010 | $4.72B | -4.4% | -$214.79M | ||
| 2009 | $4.93B | — | — |
Operating Income values are taken from AbbVie's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, AbbVie (ABBV) operating income totalled $20.09B – surged 119.9% year-over-year.
Through 2020–2025 (5 years), AbbVie operating income delivered a +12.1% annualised rate; with the latest reading among the more recent periods of the dataset.
2025 marks the peak operating income at $20.09B, with the historical low of $3.41B recorded in 2014.
AbbVie (ABBV) sits 5th of 8 Healthcare peers we track on this metric, against a peer median of $21.23B.
AbbVie Operating Income by Year
AbbVie Operating Income 2025: $20.09B
AbbVie operating income in 2025 was $20.09B, surged 119.9% from 2024. This figure represents the highest annual value in the available history.
AbbVie Operating Income 2024: $9.14B
AbbVie operating income in 2024 was $9.14B, declined 28.4% below 2023.
AbbVie Operating Income 2023: $12.76B
AbbVie operating income in 2023 was $12.76B, declined 29.6% below 2022.
AbbVie Operating Income 2022: $18.12B
AbbVie operating income in 2022 was $18.12B, edged up 1.1% from 2021.
AbbVie Operating Income 2021: $17.92B
AbbVie operating income in 2021 was $17.92B.
See more financial history for AbbVie (ABBV).
Sector peers — Operating Income
Companies in the same sector as AbbVie, ranked by their latest operating income.
| Company | Operating Income | Sector |
|---|---|---|
| Novo Nordisk (NVO) | $127.66B | Healthcare |
| Eli Lilly (LLY) | $29.70B | Healthcare |
| Johnson & Johnson (JNJ) | $25.60B | Healthcare |
| Merck & Co. (MRK) | $23.49B | Healthcare |
| UnitedHealth Group (UNH) | $18.96B | Healthcare |
| AstraZeneca (AZN) | $13.74B | Healthcare |
| Amgen (AMGN) | $10.68B | Healthcare |
| Thermo Fisher Scientific (TMO) | $8.11B | Healthcare |
Frequently asked questions
What is AbbVie's operating income?
Latest reported operating income for AbbVie (ABBV) is $17.34B (period ending March 31, 2026).
How has AbbVie operating income changed year-over-year?
AbbVie (ABBV) operating income changed +119.9% year-over-year on the latest annual filing.
What is the long-term growth rate of AbbVie operating income?
AbbVie (ABBV) operating income compound annual growth rate is +12.1% over the most recent 5 years available.
When did AbbVie operating income hit its highest annual value?
AbbVie operating income reached its highest annual value of $20.09B in 2025.
What was AbbVie operating income in 2024?
AbbVie (ABBV) operating income in 2024 was $9.14B.
What was AbbVie operating income in 2025?
AbbVie (ABBV) operating income in 2025 was $20.09B.
ABBV Key Financials
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
ABBV Overview
Company profile, financial tools, and key metrics
ABBV Revenue Counter
Earns $1,992 every second. See per minute, hour, and day.
ABBV Earnings Counter
Earns $115.39 per second net profit. See per minute, hour, and day.
ABBV Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
ABBV What If Invested
What if you had invested $1,000? See historical returns from any date.
ABBV How It Makes Money
Discover visual breakdown of $62.82B in revenue — where it comes from and where it goes.
ABBV Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ABBV Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ABBV Daily Price Character
Steady · 53.6% historical win rate (green days). Streaks & record days.
ABBV Buybacks
0.39% TTM buyback yield. Shareholder yield & SBC comparison.
ABBV Dividend Profile
Yield: 2.97%. Safety: 4/8. See full history.
ABBV Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
ABBV Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.
ABBV Dividend Capture
Historical pre-ex touch stats, gap distribution, after-tax calculator, and a backtest simulator (limit-order vs MOC exit).